MeSH D012127 - newborn respiratory distress syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Beractant | Survanta | 1991-07-01 | |||
| Chiesi Farmaceutici | Poractant alfa | Curosurf | 1999-11-18 | |||
| Linde Healthcare | Nitric oxide | INOmax | 2001-08-01 | |||
| Mallinckrodt | Nitric oxide | INOmax | 2029-06-03 | 1999-12-23 | $118.3 M | Y2016 |
| ONY Biotech | Calfactant | Infasurf | 1998-07-01 | |||
| Vero Biotech | Nitric oxide | Genosyl | 2022-02-23 | 2019-12-20 |
Clinical Trials
Historical Success Rate
Phase 1
25%1/4
Phase 2
33%2/6
Phase 3
86%6/7
Approved: 4Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use